Abstract. Resistance to antimalarial chemotherapy is one of the greatest difficulties for the control of malaria transmission. Seventy patients with Plasmodium falciparum malaria were included in a study of resistance to chloroquine and sulfadoxine-pyrimethamine therapy. Resistance levels RI, RII, and RIII were established. Eighteen infections (51%) cleared after chloroquine treatment and did not recur within 28 days of follow-up; these were classified as sensitive. Ten infections (29%) were resistant at the RI level. Resistance at level RII was observed in 5 (14%) cases, and RIII resistance was demonstrated in 2 infections (6%). With sulfadoxine-pyrimethamine, 28 (80%) infections were classified as sensitive. Six infections (17%) showed resistance at level RII, and 1 (3%) infection was resistant at the RI level. Resistance at level RIII was not observed. In a microtest for chloroquine and sulfadoxinepyrimethamine sensitivity in vitro, schizont development was accomplished successfully in 70 blood samples. In vitro resistance to chloroquine was demonstrated in 15 of 70 (21%) of all isolates. Eight of 70 (11%) of all isolates showed resistance to sulfadoxine-pyrimethamine. Diversity of response of P. falciparum to the studied antimalarial drugs in the Guayana area of Venezuela is considered a problem restricting the control of malaria in this geographical area. A constant evaluation program monitoring P. falciparum drug sensitivity is necessary for preserving the efficacy of the established treatment.After a successful eradication program implemented over several decades, malaria is now endemic in Venezuela in patchy forest areas where activities associated with gold mining are limiting control efforts. From 1992 to 1995, Plasmodium falciparum infections and outbreaks were registered only in remote areas in southern Venezuela, in 11 municipalities that are located in Bolívar State and Amazonas and Delta Amacuro territories. Bolívar State has contributed more than 60% of all malaria cases in Venezuela; of these, 20% correspond to P. falciparum infections. On average, the infection rates of the parasite reach 2 cases per 1,000 inhabitants among a population composed mainly of gold and diamond miners and indigenous groups.Resistance to antimalarial chemotherapy is one of the obstacles for the control of malaria transmission in various regions of the world. The adequate use of antimalarial drugs is essential for reducing the high morbidity and mortality associated with P. falciparum malaria in nonimmune hosts. Therefore, knowledge of the geographical distribution of P. falciparum strains that are resistant and the identification of the severity of this resistance are important in the choice of an effective therapeutic regimen.Chloroquine resistance was first reported in Venezuela, 1 and soon after was confirmed in several countries. Since 1975, very few studies on resistant P. falciparum strains have been carried out in Venezuela; some of them have shown different resistance levels in vivo for chloroquine 2 (Navarret...